HCN Investigates: What Are Synthetic Cannabinoids?

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Related Posts

HCN NECANN Interviews: Rick Laneve: Founder & CEO of Accounting Buds
High Finance with Peter Su ft. Marc Hauser: Founder: Cannabis Musings
High Finance with Peter Su ft. Kathryn Tucker: Director of Advocacy: National Psychedelics Association
High Finance with Peter Su ft. Frank Colombo: Managing Director: Viridian Capital Advisors
MJBizCon25 Interviews: Seth Yakatan: CEO: Katan Associates International

Latest News

Planet 13 Reports Q1 2026 Financial Results

May 14th, 2026|

LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress ...

MariMed Reports Q1 2026 Financial Results

May 14th, 2026|

NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and ...

Grown Rogue Reports Q1 2026 Financial Results

May 13th, 2026|

MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus ...